Facilitating a transparent and tailored scientific discussion about the added value of animal feeding trials as well as in vitro and in silico approaches with whole food/feed for the risk assessment of genetically modified plants Joachim SchiemannPablo SteinbergBernard Salles Letter to the Editor Open access 02 October 2014 Pages: 2067 - 2069
The virtual liver: state of the art and future perspectives Dirk DrasdoJohannes BodeJan G. Hengstler Editorial 21 October 2014 Pages: 2071 - 2075
Grouping of nanomaterials for risk assessment Hermann M. Bolt Editorial 21 November 2014 Pages: 2077 - 2078
Current research on cell death mechanisms Hermann M. BoltHassan AhmedSeddik Hammad Editorial 14 November 2014 Pages: 2079 - 2082
Standard compounds for establishment of in vitro test systems J. G. HengstlerR. MarchanH. M. Bolt Editorial 30 October 2014 Pages: 2083 - 2084
In vitro systems: current limitations and future perspectives Ahmed GhallabH. M. Bolt Editorial 05 November 2014 Pages: 2085 - 2087
Current developments in nanosafety research Seddik HammadHermann M. Bolt Editorial 25 November 2014 Pages: 2089 - 2091
Reviews on cutting-edge topics in toxicology Hermann M. Bolt Editorial 27 November 2014 Pages: 2097 - 2097
SEURAT-1 liver gold reference compounds: a mechanism-based review Paul JenningsMichael SchwarzJeffrey S. Wiseman Review Article 14 November 2014 Pages: 2099 - 2133
Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models F. OeschE. FabianR. Landsiedel Review Article Open access 05 November 2014 Pages: 2135 - 2190
Manufactured nanomaterials: categorization and approaches to hazard assessment Thomas GebelHeidi FothJan Georg Hengstler Review Article 19 October 2014 Pages: 2191 - 2211
Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease Keng Gat LimAlexander I. GrayNigel J. Pyne Review Article 25 October 2014 Pages: 2213 - 2232
Combination therapy with nilotinib for drug-sensitive and drug-resistant BCR-ABL-positive leukemia and other malignancies Ellen WeisbergAtsushi NonamiJames D. Griffin Review Article 21 October 2014 Pages: 2233 - 2242
U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells Tomas SmutnyMichal BitmanPetr Pavek Molecular Toxicology 14 May 2014 Pages: 2243 - 2259
Toxicogenomics directory of chemically exposed human hepatocytes Marianna GrinbergRegina M. StöberJan G. Hengstler In vitro systems 16 November 2014 Pages: 2261 - 2287
Ninety-day oral toxicity studies on two genetically modified maize MON810 varieties in Wistar Han RCC rats (EU 7th Framework Programme project GRACE) Dagmar ZeljenkováKatarína AmbrušováPablo Steinberg Biologics Open access 02 October 2014 Pages: 2289 - 2314
Safety limits for elements in toys: a comparison between the old and the new European toys safety directive Bärbel ViethRalph PirowAndreas Luch Letter to the Editor, News and Views 06 November 2014 Pages: 2315 - 2318
Commentary to Pastore et al. (2014): Epidermal growth factor receptor signaling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors Kozue TakedaYoshiyuki KawamotoMasashi Kato Letter to the Editor 24 September 2014 Pages: 2319 - 2320
Replica to K. Takeda et al. Commentary to Pastore et al. (2014): Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors Saveria PastoreDaniela LulliGiampiero Girolomoni Letter to the Editor, News and Views 05 November 2014 Pages: 2321 - 2322
Workshop report: Identifying opportunities for global integration of toxicogenomics databases, 26–27 June 2013, Research Triangle Park, NC, USA Diana M. HendrickxRebecca R. BoylesAllen Dearry Meeting Reports Open access 19 October 2014 Pages: 2323 - 2332